Biodesix Market Cap

Biodesix has a market cap or net worth of $142.92 million as of April 18, 2024. Its market cap has increased by 12.44% in one year.

Market Cap

142.92M

Enterprise Value

177.32M

1-Year Change

12.44%

Ranking

#3876

Market Cap Chart

Since the IPO on October 28, 2020, Biodesix's market cap has decreased from $472.57M to $142.92M, a decrease of -69.76%. That is a compound annual growth rate of -29.14%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2024	117.30M	-3.22%
Apr 16, 2024	121.20M	-
Apr 15, 2024	121.20M	1.68%
Apr 12, 2024	119.20M	-0.83%
Apr 11, 2024	120.20M	0.84%
Apr 10, 2024	119.20M	-3.17%
Apr 9, 2024	123.10M	-9.95%
Apr 8, 2024	136.70M	0.74%
Apr 5, 2024	135.70M	-7.31%
Apr 4, 2024	146.40M	-2.59%
Apr 3, 2024	150.30M	4.09%
Apr 2, 2024	144.40M	1.33%
Apr 1, 2024	142.50M	2.81%
Mar 28, 2024	138.60M	-0.72%
Mar 27, 2024	139.60M	-0.71%
Mar 26, 2024	140.60M	0.72%
Mar 25, 2024	139.60M	4.33%
Mar 22, 2024	133.80M	2.22%
Mar 21, 2024	130.90M	-
Mar 20, 2024	130.90M	-2.17%
Mar 19, 2024	133.80M	-
Mar 18, 2024	133.80M	-6.11%
Mar 15, 2024	142.50M	4.24%
Mar 14, 2024	136.70M	-4.07%
Mar 13, 2024	142.50M	-1.99%

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Omega Therapeutics	141.20M
Inotiv	139.91M
Amylyx Pharmaceuticals	139.63M
DBV Technologies	138.54M
Relmada Therapeutics	138.50M
Zura Bio	136.88M
Repare Therapeutics	135.83M
Sagimet Biosciences	135.00M

Market Cap Rankings